Lancaster EPrints

A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.

El-Agnaf, Omar M. A. and Paleologou, Katerina E. and Greer, Brett and Abogrein, Abdulmawala M. and King, Jennifer and Salem, Sultan A. and Fullwood, Nigel J. and Benson, Fiona E. and Hewitt, Rebecca and Ford, Kirstie J. and Martin, Frank and Harriott, Patrick and Cookson, Mark R. and Allsop, David (2004) A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. FASEB Journal, 18 (11). pp. 1315-1317. ISSN 0892-6638

Full text not available from this repository.
Item Type: Article
Journal or Publication Title: FASEB Journal
Subjects: Q Science > QH Natural history > QH301 Biology
Departments: Faculty of Science and Technology > Lancaster Environment Centre
Faculty of Health and Medicine > Biomedical & Life Sciences
ID Code: 8843
Deposited By: Prof David Allsop
Deposited On: 15 May 2008 11:46
Refereed?: Yes
Published?: Published
Last Modified: 09 Apr 2014 22:14
Identification Number:
URI: http://eprints.lancs.ac.uk/id/eprint/8843

Actions (login required)

View Item